A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of Influenza B globular head vaccines

Authors:

Abstract
No abstract available
Funding Information
  • Office of the Assistant Secretary for Preparedness and Response
  • Biomedical Advanced Research and Development Authority
  • Department of Health and Human Services
  • VaxInnate Corporation

This publication has 16 references indexed in Scilit: